ALTEOGEN Market Cap

ALTEOGEN has a market cap or net worth of 26.27 trillion as of September 12, 2025. Its market cap has increased by 69.04% in one year.

Market Cap

26.27T

Enterprise Value

26.01T

Revenue

158.06B

Ranking

n/a

PE Ratio

278.58

Stock Price

491,500.00

Market Cap Chart

Since December 12, 2014, ALTEOGEN's market cap has increased from 119.96B to 26.27T, an increase of 21,796.74%. That is a compound annual growth rate of 65.02%.

Market Cap History

Date	Market Cap	% Change
Sep 12, 2025	26.27T	59.24%
Dec 30, 2024	16.49T	221.05%
Dec 28, 2023	5,137.84B	160.78%
Dec 29, 2022	1,970.17B	-38.41%
Dec 30, 2021	3,198.72B	-36.62%
Dec 30, 2020	5,046.50B	442.81%
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro
Dec 30, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	73.74T
Celltrion	37.89T
Yuhan	8,894.66B
SK Biopharmaceuticals	8,653.61B
Peptron	7,245.48B
PharmaResearch	6,784.44B
ABL Bio	5,752.22B
LigaChem Biosciences	5,611.07B

Market Cap Rankings